Abstract
Accumulating studies have raised concerns about gut dysbiosis associating autism spectrum disorder (ASD) and its related symptoms. However, the effect of gut microbiota modification on the Chinese ASD population and its underlying mechanism were still elusive. Herein, we enrolled 24 ASD children to perform the first course of fresh washed microbiota transplantation (WMT), 18 patients decided to participate the second course, 13 of which stayed to participate the third course, and there were 8 patients at the fourth course. Then we evaluated the effects of fresh WMT on these patients and their related symptoms. Our results found that the sleeping disorder symptom was positively interrelated to ASD, fresh WMT significantly alleviated ASD and its sleeping disorder and constipation symptoms. In addition, WMT stably and continuously downregulated Bacteroides/Flavonifractor/Parasutterella while upregulated Prevotella_9 to decrease toxic metabolic production and improve detoxification by regulating glycolysis/myo-inositol/D-glucuronide/D-glucarate degradation, L-1,2-propanediol degradation, fatty acid β-oxidation. Thus, our results suggested that fresh WMT moderated gut microbiome to improve the behavioral and sleeping disorder symptoms of ASD via decrease toxic metabolic production and improve detoxification. Which thus provides a promising gut ecological strategy for ASD children and its related symptoms treatments.
Similar content being viewed by others
Data Availability
The datasets of 16S rRNA gene sequencing data presented in this study can be found in the NCBI Sequence Read Archive (SRA) (accession number: PRJNA744027).
References
American Psychiatric Association, DSM-5 Task Force. (2013). Diagnostic and statistical manual of mental disorders DSM-5™ (5th ed.). American Psychiatric Publishing, Inc. https://doi.org/10.1176/appi.books.9780890425596
Baio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., Kurzius-Spencer, M., Zahorodny, W., Robinson Rosenberg, C., White, T., et al. (2018). Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 Sites, United States, 2014. Morbidity and Mortality Weekly Report. Surveillance Summaries, 67, 1–23.
Bruni, O., Ottaviano, S., Guidetti, V., Romoli, M., Innocenzi, M., Cortesi, F., & Giannotti, F. (1996). The Sleep Disturbance Scale for Children (SDSC). Construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescence. Journal of Sleep Research, 5, 251–261.
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010). QIIME allows analysis of high-throughput community sequencing data. Nature Methods, 7, 335–336.
Cerminara, M., Spirito, G., Pisciotta, L., Squillario, M., Servetti, M., Divizia, M. T., Lerone, M., Berloco, B., Boeri, S., Nobili, L., et al. (2021). Case report: whole exome sequencing revealed disease-causing variants in two genes in a patient with autism spectrum disorder, intellectual disability, hyperactivity, sleep and gastrointestinal disturbances. Frontiers in Genetics, 12, 625564.
Christensen, D. L., Braun, K. V. N., Baio, J., Bilder, D., Charles, J., Constantino, J. N., Daniels, J., Durkin, M. S., Fitzgerald, R. T., Kurzius-Spencer, M., et al. (2018). Prevalence and characteristics of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2012. Morbidity and Mortality Weekly Report. Surveillance Summaries, 65, 1–23.
Cole, J. R., Wang, Q., Fish, J. A., Chai, B., McGarrell, D. M., Sun, Y., Brown, C. T., Porras-Alfaro, A., Kuske, C. R., & Tiedje, J. M. (2014). Ribosomal database project: data and tools for high throughput rRNA analysis. Nucleic Acids Research, 42, D633–D642.
Craven, L., Rahman, A., Nair Parvathy, S., Beaton, M., Silverman, J., Qumosani, K., Hramiak, I., Hegele, R., Joy, T., Meddings, J., et al. (2020). Allogenic fecal microbiota transplantation in patients with nonalcoholic fatty liver disease improves abnormal small intestinal permeability: a randomized control trial. The American Journal of Gastroenterology, 115, 1055–1065.
Cui, B., Feng, Q., Wang, H., Wang, M., Peng, Z., Li, P., Huang, G., Liu, Z., Wu, P., Fan, Z., et al. (2015). Fecal microbiota transplantation through mid-gut for refractory Crohn’s disease: safety, feasibility, and efficacy trial results. Journal of Gastroenterology and Hepatology, 30, 51–58.
Douglas, G. M., Maffei, V. J., Zaneveld, J. R., Yurgel, S. N., Brown, J. R., Taylor, C. M., Huttenhower, C., & Langille, M. G. I. (2020). PICRUSt2 for prediction of metagenome functions. Nature Biotechnology, 38, 685–688.
Edgar, R. C. (2010). Search and clustering orders of magnitude faster than BLAST. Bioinformatics, 26, 2460–2461.
Entner, N., & Doudoroff, M. (1952). Glucose and gluconic acid oxidation of Pseudomonas saccharophila. The Journal of Biological Chemistry, 196, 853–862.
Farmer, C., & Aman, M. G. (2020). Aberrant behavior checklist. In F. Volkmar (Ed.), Encyclopedia of autism spectrum disorders. USA: Springer, New York.
Farsalinos, K. E., & Polosa, R. (2014). Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Therapeutic Advances in Drug Safety, 5, 67–86.
Fecal Microbiota Transplantation-standardization Study Group. (2020). Nanjing consensus on methodology of washed microbiota transplantation. Chinese Medical Journal, 133, 2330–2332.
Ghosn, F., Navalón, P., Pina-Camacho, L., Almansa, B., Sahuquillo-Leal, R., Moreno-Giménez, A., Diago, V., Vento, M., & García-Blanco, A. (2022). Early signs of autism in infants whose mothers suffered from a threatened preterm labour: a 30-month prospective follow-up study. European Child & Adolescent Psychiatry, 31, 1–13.
Hua, X., Zhu, J., Yang, T., Guo, M., Li, Q., Chen, J., & Li, T. (2020). The gut microbiota and associated metabolites are altered in sleep disorder of children with autism spectrum disorders. Frontiers in Psychiatry, 11, 855.
Hunter, P. (2023). Autism therapy at crossroads. EMBO Reports, 24, e56915.
Kang, D. W., Adams, J. B., Gregory, A. C., Borody, T., Chittick, L., Fasano, A., Khoruts, A., Geis, E., Maldonado, J., McDonough-Means, S., et al. (2017). Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome, 5, 10.
Keshtkarjahromi, M., Palvadi, K., Shah, A., Dempsey, K. R., & Tonarelli, S. (2021). Psychosis and catatonia in fragile X syndrome. Cureus, 13, e12843.
Kramer, I., Lipkin, P. H., Marvin, A. R., & Law, P. A. (2015). A genetic multimutation model of autism spectrum disorder fits disparate twin concordance data from the USA and Canada. International Scholarly Research Notices, 2015, 519828.
Lewis, S. J., & Heaton, K. W. (1997). Stool form scale as a useful guide to intestinal transit time. Scandinavian Journal of Gastroenterology, 32, 920–924.
Li, M., Liang, P., Li, Z., Wang, Y., Zhang, G., Gao, H., Wen, S., & Tang, L. (2015). Fecal microbiota transplantation and bacterial consortium transplantation have comparable effects on the re-establishment of mucosal barrier function in mice with intestinal dysbiosis. Frontiers in Microbiology, 6, 692.
Liu, X. J., Wu, L. H., Xie, W. R., & He, X. X. (2020). Faecal microbiota transplantation simultaneously ameliorated patient’s essential tremor and irritable bowel syndrome. Psychogeriatrics, 20, 796–798.
Liu, Z., Mao, X., Dan, Z., Pei, Y., Xu, R., Guo, M., Liu, K., Zhang, F., Chen, J., Su, C., et al. (2021). Gene variations in autism spectrum disorder are associated with alteration of gut microbiota, metabolites and cytokines. Gut Microbes, 13, 1–16.
Lynch, S. V., & Pedersen, O. (2016). The human intestinal microbiome in health and disease. The New England Journal of Medicine, 375, 2369–2379.
Maenner, M. J., Shaw, K. A., Baio, J., Washington, A., Patrick, M., DiRienzo, M., Christensen, D. L., Wiggins, L. D., Pettygrove, S., Andrews, J. G., et al. (2020). Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2016. Morbidity and Mortality Weekly Report. Surveillance Summaries, 69, 1–12.
Magoč, T., & Salzberg, S. L. (2011). FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics, 27, 2957–2963.
Marcella, C., Cui, B., Kelly, C. R., Ianiro, G., Cammarota, G., & Zhang, F. (2021). Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020. Alimentary Pharmacology & Therapeutics, 53, 33–42.
Moon, T. S., Yoon, S. H., Lanza, A. M., Roy-Mayhew, J. D., & Prather, K. L. (2009). Production of glucaric acid from a synthetic pathway in recombinant Escherichia coli. Applied and Environmental Microbiology, 75, 589–595.
Murata, M., Noda, K., & Ishida, S. (2020). Pathological role of unsaturated aldehyde acrolein in diabetic retinopathy. Frontiers in Immunology, 11, 589531.
Nitschke, A., Deonandan, R., & Konkle, A. T. (2020). The link between autism spectrum disorder and gut microbiota: a scoping review. Autism, 24, 1328–1344.
Ostadkarampour, M., & Putnins, E. E. (2021). Monoamine oxidase inhibitors: a review of their anti-inflammatory therapeutic potential and mechanisms of action. Frontiers in Pharmacology, 12, 676239.
Panzer, A. R., & Lynch, S. V. (2020). Gut microbial regulation of autism spectrum disorder symptoms. Trends in Endocrinology and Metabolism, 31, 809–811.
Price, M. N., Dehal, P. S., & Arkin, A. P. (2009). FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Molecular Biology and Evolution, 26, 1641–1650.
Prochazkova, P., Roubalova, R., Dvorak, J., Tlaskalova-Hogenova, H., Cermakova, M., Tomasova, P., Sediva, B., Kuzma, M., Bulant, J., Bilej, M., et al. (2019). Microbiota, microbial metabolites, and barrier function in a patient with anorexia nervosa after fecal microbiota transplantation. Microorganisms, 7, 338.
Rao, J., Xie, R., Lin, L., Jiang, J., Du, L., Zeng, X., Li, G., Wang, C., & Qiao, Y. (2021). Fecal microbiota transplantation ameliorates gut microbiota imbalance and intestinal barrier damage in rats with stress-induced depressive-like behavior. The European Journal of Neuroscience, 53, 3598–3611.
Rhee, S. H., Pothoulakis, C., & Mayer, E. A. (2009). Principles and clinical implications of the brain-gut-enteric microbiota axis. Nature Reviews Gastroenterology & Hepatology, 6, 306–314.
Roussin, L., Prince, N., Perez-Pardo, P., Kraneveld, A. D., Rabot, S., & Naudon, L. (2020). Role of the gut microbiota in the pathophysiology of autism spectrum disorder: clinical and preclinical evidence. Microorganisms, 8, 1369.
Sommer, F., Anderson, J. M., Bharti, R., Raes, J., & Rosenstiel, P. (2017). The resilience of the intestinal microbiota influences health and disease. Nature Reviews Microbiology, 15, 630–638.
Tafti, M., Petit, B., Chollet, D., Neidhart, E., de Bilbao, F., Kiss, J. Z., Wood, P. A., & Franken, P. (2003). Deficiency in short-chain fatty acid beta-oxidation affects theta oscillations during sleep. Nature Genetics, 34, 320–325.
Vendrik, K. E. W., Ooijevaar, R. E., de Jong, P. R. C., Laman, J. D., van Oosten, B. W., van Hilten, J. J., Ducarmon, Q. R., Keller, J. J., Kuijper, E. J., & Contarino, M. F. (2020). Fecal microbiota transplantation in neurological disorders. Frontiers in Cellular and Infection Microbiology, 10, 98.
Walaszek, Z., Szemraj, J., Hanausek, M., Adams, A. K., & Sherman, U. (1996). D-Glucaric acid content of various fruits and vegetables and cholesterol-lowering effects of dietary D-glucarate in the rat. Nutrition Research, 16, 673–681.
Wang, B., Cao, F., & Boyland, J. T. (2019). Addressing autism spectrum disorders in China. New Directions for Child and Adolescent Development, 163, 137–162.
Xie, W. R., Yang, X. Y., Xia, H. H., Wu, L. H., & He, X. X. (2019). Hair regrowth following fecal microbiota transplantation in an elderly patient with alopecia areata: a case report and review of the literature. World Journal of Clinical Cases, 7, 3074–3081.
Ye, Z. N., Xia, H. H., Zhang, R., Li, L., Wu, L. H., Liu, X. J., Xie, W. R., & He, X. X. (2020). The efficacy of washed microbiota transplantation on Helicobacter pylori eradication: a pilot study. Gastroenterology Research and Practice, 2020, 8825189.
Żebrowska, P., Łaczmańska, I., & Łaczmański, Ł. (2021). Future directions in reducing gastrointestinal disorders in children with ASD using fecal microbiota transplantation. Frontiers in Cellular and Infection Microbiology, 11, 630052.
Zhang, M., Chu, Y., Meng, Q., Ding, R., Shi, X., Wang, Z., He, Y., Zhang, J., Liu, J., Zhang, J., Yu, J., Kang, Y., & Wang, J. (2020a). A quasi-paired cohort strategy reveals the impaired detoxifying function of microbes in the gut of autistic children. Science Advances, 6, eaba3760.
Zhang, T., Long, C., Cui, B., Buch, H., Wen, Q., Li, Q., Ding, X., Ji, G., & Zhang, F. (2020b). Colonic transendoscopic tube-delivered enteral therapy (with video): a prospective study. BMC Gastroenterology, 20, 135.
Zhang, T., Lu, G., Zhao, Z., Liu, Y., Shen, Q., Li, P., Chen, Y., Yin, H., Wang, H., Marcella, C., et al. (2020c). Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening. Protein & Cell, 11, 251–266.
Zheng, Y. M., Chen, X. Y., Cai, J. Y., Yuan, Y., Xie, W. R., Xu, J. T., Xia, H. H., Zhang, M., He, X. X., & Wu, L. H. (2021). Washed microbiota transplantation reduces proton pump inhibitor dependency in nonerosive reflux disease. World Journal of Gastroenterology, 27, 513–522.
Zhong, H. J., Zeng, H. L., Cai, Y. L., Zhuang, Y. P., Liou, Y. L., Wu, Q., & He, X. X. (2021). Washed microbiota transplantation lowers blood pressure in patients with hypertension. Frontiers in Cellular and Infection Microbiology, 11, 679624.
Zhou, H., Xu, X., Yan, W., Zou, X., Wu, L., Luo, X., Li, T., Huang, Y., Guan, H., Chen, X., et al. (2020). Prevalence of autism spectrum disorder in China: a nationwide multi-center population-based study among children aged 6 to 12 years. Neuroscience Bulletin, 36, 961–971.
Zółtaszek, R., Hanausek, M., Kiliańska, Z. M., & Walaszek, Z. (2008). The biological role of D-glucaric acid and its derivatives: potential use in medicine. Advances in Hygiene and Experimental Medicine, 62, 451–462.
Acknowledgements
We gratefully thank all enrolled health donors, enrolled ASD children and their families for participating in this study. We then do appreciate all funders who have provided the financial supports for this study.
This study was supported by Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine (ZYYCXTD-C-202208), Guangdong Provincial Key Laboratory of TCM Pathgenesis and Prescriptions of Heart and Spleen Diseases (2022B1212010012), Special Project for Research and Development in Key areas of Guangdong Province (2020B1111100011), the Natural Science Foundation of Guangdong Province (2018A030313639, 2019A1515010125, 2023A1515010751), Guangdong Key Discipline Research Project of Department of Education of Guangdong Province (2019-GDXK-0013), and COVID-19 Epidemic Prevention and Control Special Research Project of Department of Education of Guangdong Province (2020KZDZX1132). Basic and Applied Basic Research Project of Guangzhou Basic Research Program (202201010134), Discipline Collaborative Innovation Team of Guangzhou University of Traditional Chinese Medicine (2021xk36). All funders had no role in the design of the study and collection, analysis, interpretation of data and in writing the manuscript, the decision to submit the manuscript for publication.
Author information
Authors and Affiliations
Contributions
X-XH and H-FP conceived and designed the study. N-HL, H-QL, J-YZ, M-LZ, and L-HW carried out sample collection 340 and washed microbiota transplantation. N-HL and J-YZ performed data analyses. N-HL and H-QL prepared the manuscript draft, X-XH and H-FP revised the manuscripts. X-XH submitted 342 the manuscript. All authors have read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of Interest
The authors declare that they have no competing interests.
Ethical Approval and Consent to Participate
The studies involving human participants were reviewed and approved by The Ethics Committee of the First Affiliated Hospital of Guangdong Pharmaceutical University (Approval License No. YLS2020-14). Written informed consent to participate in this study was provided by the participants' parents for the publication of data included in this article.
Consent for Publication
Not applicable.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liu, NH., Liu, HQ., Zheng, JY. et al. Fresh Washed Microbiota Transplantation Alters Gut Microbiota Metabolites to Ameliorate Sleeping Disorder Symptom of Autistic Children. J Microbiol. 61, 741–753 (2023). https://doi.org/10.1007/s12275-023-00069-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-023-00069-x